FDA NDC Directory · JSON-LD · Markdown

TEMODAR

NDC 0085-1381 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTemozolomide
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryNew Drug Application (innovator) · App NDA022277
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTEMOZOLOMIDE (2.5 mg/mL)
Marketing started20090227
Package count1

External sources

Source: openFDA. Public-domain (CC0).